Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 13Recruiting 9Active not recruiting 9Terminated 5Unknown 4Withdrawn 2Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 2Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Carcinoma, Neuroendocrine 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Carcinoma, Anaplastic 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Hodgkin Disease 1Gallbladder Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Bile Duct Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × Endocrine × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡